ContextVision AB – Company presentation held in Oslo

Stockholm, February 28th, 2019 – Today ContextVision held a company presentation in Oslo, Norway. The arrangement was held at Norne Securities AS premises at Roald Amundsens gt. 6, Oslo. Anita Tollstadius gave an update of the company’s development and shared the company’s future direction. Please find a PDF-version of the presentation attached. The presentation will […]
Read More

ContextVision on track for 2019 commercial product launch within digital pathology

STOCKHOLM – February 21, 2019 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, is closing in on a commercial product within digital pathology with a planned launch in 2019. Tests prove that ContextVision’s algorithms perform as well as pathologists and have also helped identify suspicious cancer areas that are […]
Read More

ContextVision to showcase Altumira™, AI-powered image enhancement for digital radiography at ECR 2019

With deep learning technology integrated, Altumira is specially designed to meet the demanding needs of digital radiography for both dynamic and static X-ray. At ECR, the full suite of industry-leading image enhancement products for ultrasound will be showcased. ContextVision's products deliver unsurpassed image quality for all types of ultrasound systems from handheld devices to the most advanced 3D/4D applications.
Read More

ContextVision AB invitation to company presentation

We are pleased to invite you to a presentation of Contextvision AB and its 4th quarter and full year 2018 figures at the offices of Norne Securities AS (Oslo Office), Roald Amundsens gt. 6, Oslo.   Thursday, February 28th at 11.30 Lunch will be served We are very encouraged by the developments during 2018 and […]
Read More

Meet us at ICE, Feb 17–19, 2019

Meet us at ICE 2019. The Imaging Conference and Expo (ICE). February 17–19, 2019, Tampa, Clearwater. Contact us: William McGinnis / National Sales Director North & South America, phone +1 720 32 63 228 or e-mail .
Read More